ESG

A new provider launches personalized ABA therapy in Colorado homes, addressing service gaps for children with autism with plans for a future clinic.

At SynBioBeta 2026, Ansa Biotechnologies unveils a bold on-time guarantee, challenging rivals and promising to accelerate research with its advanced DNA tech.

A new stem cell therapy promises a one-time cure for hemophilia A, and the FDA is clearing the path. Could lifelong, costly infusions become a memory?

The RTD giant is launching its first limited-edition flavor, Transfusion, using a streetwear-style 'drop' to tap into the booming golf lifestyle market.

Student entrepreneurs from 15 countries converge in San Diego to pitch world-changing ideas, from pineapple-fiber hair ties to crypto for Gen Z.

Beloved SF institution Bi-Rite Market announces a new Richmond District store, promising to revitalize a historic site and deepen its community-first mission.

Oral care leader quip and skincare giant Glowbar partner, signaling a major shift toward simplified, habit-driven wellness. What does this mean for you?

Once a hospital disinfectant, hypochlorous acid is now a skincare star. Magic Molecule's massive CVS launch signals a major shift in the beauty industry.

The largest deal in epigenetic testing sees TruDiagnostic's parent buy Dr. David Sinclair's Tally Health, aiming to make personalized longevity mainstream.

With a new industry giant on its board and fresh funding, Phagenesis is set to scale its groundbreaking neuromodulation therapy for swallowing disorders.

A new Georgia development is trading fairways for farm-to-table living, centering an entire community around food. But can this model redefine luxury?

A new partnership aims to expand a proven trenchless technology, promising to fix aging gas pipes faster, cheaper, and with far less disruption.

A novel, FDA-cleared wound therapy is rolling out to military and veteran hospitals, aiming to rewrite the rules of healing for the most complex injuries.

Anika Therapeutics posts strong Q1 results with a 13% revenue jump, but analyst caution lingers over pipeline risks and long-term sustainability.

A new FDA-cleared system from Chest Wall Innovations offers both PEEK and titanium implants, promising surgeons unprecedented versatility in treating rib fractures.

Scottish biotech EnteroBiotix secures major funding to advance its gut therapy for IBS-C, offering new hope for a disease-modifying treatment.

A first-in-class drug, NTX-2001, is now in human trials for alcohol use disorder, offering a new mechanism of action in a field with few options.

HitGen Inc.'s latest sustainability report signals a deep integration of ESG, leveraging its AI-driven R&D platform for both health and environmental gains.

A Cairo hospital's innovative model earns global praise, using revenue from international patients to provide free, world-class cancer care for children.

Henlius and Organon's POHERDY gains EC approval, set to expand access and lower costs for a critical breast cancer therapy across the European Union.